Literature DB >> 23395319

Positron emission tomography-computed tomography in liver imaging.

Bhuey Sharma1, Axel Martin, Imene Zerizer.   

Abstract

The relatively new technique of positron emission tomography (PET) that incorporates both anatomy and function is increasingly being utilized in oncological imaging. This review assesses the use of PET of the liver for optimal and appropriate patient clinical management. The role of PET in both liver-lesion detection and characterization is discussed (including the context of primary liver malignancy, hepatocellular carcinoma, cholangiocarcinoma, metastatic disease from colorectal cancer and other tumor types). The use of functional PET imaging for prognostication, efficacy pre-liver transplantation, response assessment including post-radio frequency ablation and Yttrium-90 radioembolization, as well as the emerging and future roles of novel PET biomarkers, is also highlighted.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395319     DOI: 10.1053/j.sult.2012.11.006

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  7 in total

Review 1.  Endoscopic assessment and management of biliary strictures.

Authors:  M F Dawwas; K W Oppong; G J Webster
Journal:  Frontline Gastroenterol       Date:  2015-06-17

Review 2.  A review on the added value of whole-body MRI in metastatic lobular breast cancer.

Authors:  Basrull N Bhaludin; Nina Tunariu; Dow-Mu Koh; Christina Messiou; Alicia F Okines; Sophie E McGrath; Alistair E Ring; Marina M Parton; Bhupinder Sharma; Tanja Gagliardi; Steven D Allen; Romney Pope; Stephen R D Johnston; Kate Downey
Journal:  Eur Radiol       Date:  2022-04-06       Impact factor: 7.034

3.  Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.

Authors:  Maria-Angéla Castilla-Lièvre; Dominique Franco; Philippe Gervais; Bertrand Kuhnast; Hélène Agostini; Lysiane Marthey; Serge Désarnaud; Badia-Ourkia Helal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

4.  Appropriateness criteria of FDG PET/CT in oncology.

Authors:  Archi Agrawal; Venkatesh Rangarajan
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 5.  PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease.

Authors:  Tuo Shao; Lee Josephson; Steven H Liang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

Review 6.  18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic Review.

Authors:  Jérôme Ghidaglia; Nicolas Golse; Alina Pascale; Mylène Sebagh; Florent L Besson
Journal:  Front Med (Lausanne)       Date:  2022-07-07

7.  Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.

Authors:  Yuekai Li; Fengcai Li; Xin Li; Lili Qu; Jiankui Han
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.